首页 > 市场调查报告书 > 医疗设备

导管

市场调查报告书

商品编码

1534246

全球静脉 (IV) 设备市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Intravenous (IV) Equipment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 179 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球静脉（IV）设备市场需求预计将从2023年的214.2亿美元达到2032年近399.8亿美元的市场规模，2024-2032年研究期间的复合年增长率为7.18%。

静脉 (IV) 设备包括医疗保健环境中使用的一系列设备和配件，透过静脉治疗将液体、药物和营养物质直接注射到患者的血液中。其中包括 IV 导管、输液帮浦、IV 溶液袋、管道套件以及连接器和针头等配件。静脉注射设备对于提供精确剂量的药物和液体、确保住院、手术、紧急治疗和慢性病管理期间有效的患者护理至关重要。

市场动态

静脉 (IV) 设备市场是由癌症、糖尿病和心血管疾病等需要静脉治疗的慢性疾病盛行率上升所推动的。输液帮浦、导管和管道系统的技术创新提高了安全性、准确性和患者舒适度，推动了市场扩张。此外，全球医疗保健支出的增加和发展中地区医疗保健设施的扩大为市场渗透创造了机会。对家庭医疗保健解决方案和门诊护理环境的需求也促进了便携式和用户友好的静脉输液设备的采用，促进患者的活动并提高生活品质。

此外，促进病患安全和医疗保健品质标准的监管措施鼓励采用具有无线连接、整合监测系统和自动剂量计算等功能的先进静脉注射设备。医疗保健提供者和技术公司之间在产品开发和分销方面的策略合作伙伴关係增强了市场竞争力并扩大了产品组合。此外，COVID-19 大流行凸显了静脉注射治疗在重症患者管理中的重要性，推动了重症监护病房和急诊对输液帮浦、静脉输液和相关设备的即时需求。这种激增加速了对静脉输液设备製造和供应链弹性的投资，确保医疗危机期间的持续可用性。然而，定价压力、报销不确定性、感染控制和设备安全问题可能会阻碍市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球静脉 (IV) 设备市场的各个细分市场进行了包容性评估。静脉 (IV) 设备产业的成长和趋势为本研究提供了整体方法。

市场区隔

静脉 (IV) 设备市场报告的这一部分提供了国家和区域层面的细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按产品分类

静脉导管
管理集
点滴帮浦
固定装置
滴水室
旋塞阀和止回阀
无需连接器
其他的

按最终用户

医院和诊所
诊断中心
门诊手术中心
其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲静脉 (IV) 设备市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。静脉 (IV) 设备市场的主要参与者包括 B. Braun Melsungen AG、3M、Terumo Corporation、Abbott、Teleflex Incorporated、BD、Henry Schein Inc.、Smiths Medical、Baxter、Ascor SA、Moog Inc.、AngioDynamics。 Inc.、Fresenius SE & Co. KGaA、Animas LLC、Arcomed Ag、International Win Ltd。合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 8 章：静脉 (IV) 设备公司的竞争格局

静脉（IV）设备市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 9 章：公司简介

顶级公司市占率分析
市场集中度
B. Braun Melsungen AG

公司概况
公司收入
产品
最新动态

公司概况
公司收入
产品
最新动态

Terumo Corporation

公司概况
公司收入
产品
最新动态

Abbott

公司概况
公司收入
产品
最新动态

Teleflex Incorporated

公司概况
公司收入
产品
最新动态

公司概况
公司收入
产品
最新动态

Henry Schein Inc.

公司概况
公司收入
产品
最新动态

Smiths Medical

公司概况
公司收入
产品
最新动态

Baxter

公司概况
公司收入
产品
最新动态

Ascor SA

公司概况
公司收入
产品
最新动态

Moog Inc.

公司概况
公司收入
产品
最新动态

AngioDynamics.

公司概况
公司收入
产品
最新动态

ICU Medical Inc.

公司概况
公司收入
产品
最新动态

Fresenius SE & Co. KGaA

公司概况
公司收入
产品
最新动态

Animas LLC

公司概况
公司收入
产品
最新动态

Arcomed Ag

公司概况
公司收入
产品
最新动态

International Win Ltd

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR112115319

The global demand for Intravenous (IV) Equipment Market is presumed to reach the market size of nearly USD 39.98 Billion by 2032 from USD 21.42 Billion in 2023 with a CAGR of 7.18% under the study period 2024-2032.

Intravenous (IV) equipment encompasses a range of devices and accessories used in healthcare settings to administer fluids, medications, and nutrients directly into patients' bloodstreams via intravenous therapy. These include IV catheters, infusion pumps, IV solution bags, tubing sets, and accessories such as connectors and needles. IV equipment is crucial in delivering precise doses of medications and fluids, ensuring efficient patient care during hospitalization, surgery, emergency treatment, and chronic disease management.

MARKET DYNAMICS

The Intravenous (IV) Equipment market is driven by the rising prevalence of chronic diseases requiring intravenous therapy, such as cancer, diabetes, and cardiovascular disorders. Technological innovations in infusion pumps, catheters, and tubing systems enhance safety, accuracy, and patient comfort, driving market expansion. Moreover, rising healthcare expenditure globally and expanding healthcare facilities in developing regions create opportunities for market penetration. Demand for home healthcare solutions and ambulatory care settings also boosts the adoption of portable and user-friendly IV equipment, facilitating patient mobility and improving quality of life.

Furthermore, regulatory initiatives promoting patient safety and healthcare quality standards encourage the adoption of advanced IV equipment with features such as wireless connectivity, integrated monitoring systems, and automated dose calculations. Strategic partnerships between healthcare providers and technology firms for product development and distribution strengthen market competitiveness and expand product portfolios. Additionally, the COVID-19 pandemic has underscored the importance of IV therapy in managing critically ill patients, driving immediate demand for infusion pumps, IV fluids, and related equipment in intensive care units and emergency departments. This surge has accelerated investments in IV equipment manufacturing and supply chain resilience, ensuring continuous availability during healthcare crises. However, pricing pressures, reimbursement uncertainties, infection control, and device safety concerns may hinder market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Intravenous (IV) Equipment. The growth and trends of Intravenous (IV) Equipment industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Intravenous (IV) Equipment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

IV Catheters
Administration Sets
Infusion Pumps
Securement Devices
Drip Chambers
Stopcocks and Check Valves
Needless Connectors
Others

By End-User

Hospitals and clinics
Diagnostic Centers
Ambulatory Surgical Centers
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Intravenous (IV) Equipment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Intravenous (IV) Equipment market include B. Braun Melsungen AG, 3M, Terumo Corporation, Abbott, Teleflex Incorporated, BD, Henry Schein Inc., Smiths Medical, Baxter, Ascor S.A., Moog Inc., AngioDynamics., ICU Medical Inc., Fresenius SE & Co. KGaA, Animas LLC, Arcomed Ag, International Win Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. INTRAVENOUS (IV) EQUIPMENT - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By End-User
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL INTRAVENOUS (IV) EQUIPMENT MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data Analysis By Product
5.3. IV Catheters Historic and Forecast Sales By Regions
5.4. Administration Sets Historic and Forecast Sales By Regions
5.5. Infusion Pumps Historic and Forecast Sales By Regions
5.6. Securement Devices Historic and Forecast Sales By Regions
5.7. Drip Chambers Historic and Forecast Sales By Regions
5.8. Stopcocks and Check Valves Historic and Forecast Sales By Regions
5.9. Needless Connectors Historic and Forecast Sales By Regions
5.10. Others Historic and Forecast Sales By Regions

6. GLOBAL INTRAVENOUS (IV) EQUIPMENT MARKET ANALYSIS BY END-USER

6.1. Overview By End-User
6.2. Historical and Forecast Data Analysis By End-User
6.3. Hospitals and clinics Historic and Forecast Sales By Regions
6.4. Diagnostic Centers Historic and Forecast Sales By Regions
6.5. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL INTRAVENOUS (IV) EQUIPMENT MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE INTRAVENOUS (IV) EQUIPMENT COMPANIES

8.1. Intravenous (IV) Equipment Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF INTRAVENOUS (IV) EQUIPMENT INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. B. Braun Melsungen AG
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. 3M
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Terumo Corporation
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Abbott
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Teleflex Incorporated
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. BD
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. Henry Schein Inc.
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. Smiths Medical
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. Baxter
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. Ascor S.A.
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments
9.13. Moog Inc.
- 9.13.1 Company Overview
- 9.13.2 Company Revenue
- 9.13.3 Products
- 9.13.4 Recent Developments
9.14. AngioDynamics.
- 9.14.1 Company Overview
- 9.14.2 Company Revenue
- 9.14.3 Products
- 9.14.4 Recent Developments
9.15. ICU Medical Inc.
- 9.15.1 Company Overview
- 9.15.2 Company Revenue
- 9.15.3 Products
- 9.15.4 Recent Developments
9.16. Fresenius SE & Co. KGaA
- 9.16.1 Company Overview
- 9.16.2 Company Revenue
- 9.16.3 Products
- 9.16.4 Recent Developments
9.17. Animas LLC
- 9.17.1 Company Overview
- 9.17.2 Company Revenue
- 9.17.3 Products
- 9.17.4 Recent Developments
9.18. Arcomed Ag
- 9.18.1 Company Overview
- 9.18.2 Company Revenue
- 9.18.3 Products
- 9.18.4 Recent Developments
9.19. International Win Ltd
- 9.19.1 Company Overview
- 9.19.2 Company Revenue
- 9.19.3 Products
- 9.19.4 Recent Developments